GoldBamboo.com - Knowledge is strong medicine
  

Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:



General Topics A-Z

Furosemide Injection

Lasix Injection 



Clinical Trial: Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

This study is currently recruiting patients.

Sponsored by: Telik
Information provided by: Telik

Purpose

The purpose of this study is to determine the safety and efficacy of TLK199 in patients with myelodysplastic syndrome (MDS).

Condition Treatment or Intervention Phase
Myelodysplastic Syndromes
  Drug: TLK199 HCl Liposomes for Injection
 Phase I
Phase II

MedlinePlus related topics:  Bone Marrow Diseases

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Official Title: Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

Further Study Details: 

Expected Total Enrollment:  51

Study start: April 2002

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Histologically or cytologically confirmed diagnosis of MDS
  • Adequate liver and kidney function
  • Ineligible for, or refusing, allogeneic bone marrow transplant
  • At least 18 years of age
  • Discontinuation of growth factors (e.g., G- CSF) at least 2 weeks prior to study entry

Exclusion Criteria:

  • Pregnant or lactating women
  • History of allergy to eggs
  • Other investigational drugs within 14 days of study entry
  • Chemotherapy, radiotherapy or immunotherapy within 14 days of study entry
  • Concomitant steroids or hormones for the treatment of neoplasms

Location and Contact Information


Alabama
      University of Alabama at Birmingham, Birmingham,  Alabama,  35294,  United States; Recruiting
Lynda Leo, R.N.  204-975-9481 
Peter Emanuel, M.D.,  Principal Investigator

California
      Cancer Institute Medical Group, Los Angeles,  California,  90404,  United States; Recruiting
Sandra Binder, R.N.  310-231-2182    sbinder@cimg.org 
Lawrence D. Piro, M.D.,  Principal Investigator

Illinois
      Midwest Cancer Research Group, Skokie,  Illinois,  60077,  United States; Recruiting
Julianne Rodriguez, RN  312-981-5555 
Elaine Ortenberg, RN  312-664-5400 
Stephanie Williams, M.D.,  Principal Investigator

      University of Chicago, Chicago,  Illinois,  60637,  United States; Recruiting
Peggy Green, RN  773-702-0267    mgreen@medicine.bsd.uchicago.edu 
Richard Larson, MD,  Principal Investigator

Oregon
      Oregon Health & Science University, Portland,  Oregon,  97239,  United States; Recruiting
Laura Bradley  503-494-4467    bradlela@ohsu.edu 
Peter T Curtin, MD,  Principal Investigator

Tennessee
      The Sarah Cannon Cancer Center, Nashville,  Tennessee,  37203,  United States; Recruiting
Cindy Phelps, CCRP  615-986-4307    cphelps@tnonc.com 
Howard A Burris, III, MD,  Principal Investigator

Texas
      M.D. Anderson Cancer Center, Houston,  Texas,  77030,  United States; Recruiting
Jackie Fiorentino, RN  713-563-1688 
Stefan Faderl, M.D.,  Principal Investigator

      University of Texas Health Science Center at San Antonio, San Antonio,  Texas,  78229,  United States; Recruiting
Sydney Rodriguez, R.N.  210-617-5300  Ext. 4720    pryor@uthscsa.edu 
Jose L Ochoa-Bayona, M.D.,  Principal Investigator

      Texas Cancer Associates, Dallas,  Texas,  75231,  United States; Recruiting
Susan Guba, MD  214-739-1706    sguba@txcan.com 
Susan Guba, MD,  Principal Investigator

More Information

Study ID Numbers:  TLK199.1001
Record last reviewed:  December 2004
Last Updated:  December 15, 2004
Record first received:  May 6, 2002
ClinicalTrials.gov Identifier:  NCT00035867
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Furosemide Injection.

November 27, 2009


Page Updated: June 1, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.